Analyst Price Target is $2.33
▲ +148.23% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Acutus Medical in the last 3 months. The average price target is $2.33, with a high forecast of $3.00 and a low forecast of $1.50. The average price target represents a 148.23% upside from the last price of $0.94.
Current Consensus is
The current consensus among 5 investment analysts is to hold stock in Acutus Medical. This Hold consensus rating has held steady for over two years.
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.